US PATENT SUBCLASS 424 / 141.1
.~ Monoclonal antibody or fragment thereof (i.e., produced by any cloning technology)

Current as of: June, 1999
Click HD for Main Headings
Click for All Classes

Internet Version by PATENTEC © 1999      Terms of Use


424 /   HD   DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS

130.1  DF  IMMUNOGLOBULIN, ANTISERUM, ANTIBODY, OR ANTIBODY FRAGMENT, EXCEPT CONJUGATE OR COMPLEX OF THE SAME WITH NONIMMUNOGLOBULIN MATERIAL {18}
141.1.~ Monoclonal antibody or fragment thereof (i.e., produced by any cloning technology) {8}
142.1  DF  .~.~> Human
143.1  DF  .~.~> Binds receptor {1}
145.1  DF  .~.~> Binds hormone or other secreted growth regulatory factor, differentiation factor, or intercellular mediator (e.g., cytokine, etc.); or binds serum protein, plasma protein (e.g., tPA, etc.), or fibrin
146.1  DF  .~.~> Binds enzyme
147.1  DF  .~.~> Binds virus or component thereof {2}
150.1  DF  .~.~> Binds bacterium or component thereof or substance produced by said bacterium
151.1  DF  .~.~> Binds parasitic organism (i.e., parasitic protozoan, multicellular ectoparasite (e.g., flea, tick, mite, etc.), or multicellular endoparasite (e.g., parasitic worm, etc.)) or component thereof or substance produced by said parasitic organism
152.1  DF  .~.~> Binds eukaryotic cell or component thereof or substance produced by said eukaryotic cell {2}

DEFINITION

Classification: 424/141.1

Monoclonal antibody or fragment thereof (i.e., produced by any cloning technology):

(under subclass 130.1) Subject matter involving an antibody or fragment thereof produced by a clone of cells or cell line, which clone of cells or cell line is derived from a single antibody-producing cell or antibody-fragment-producing cell, wherein said antibody or fragment thereof is identical to all other antibodies or fragments thereof produced by that clone of cells or cell line.

(1) Note. This and the indented subclasses provide for bioaffecting and body-treating compositions of antibodies or fragments thereof as well as bioaffecting and body-treating methods of using said compositions, said antibodies, or said fragments, which antibodies or antibody fragments are produced by any cloning technology that yields identical molecules (e.g., hybridoma technology, recombinant DNA technology, etc.).

(2) Note. Monoclonal antibodies, per se, are considered compounds and are provided for elsewhere. See the search notes below..

(3) Note. Monoclonal antibodies are sometimes termed monoclonal receptors or immunological binding partners.

SEE OR SEARCH THIS CLASS, SUBCLASS:

1.49, and 1.53, for methods of using radiolabeled monoclonal antibodies or compositions thereof for bioaffecting or body-treating purposes and said compositions, per se.

9.1+, for methods of using monoclonal antibodies or compositions thereof for in vivo testing or diagnosis and said compositions, per se. 178.1+, for bioaffecting or body-treating methods of using monoclonal antibodies or fragments thereof that are conjugated to or complexed with nonimmunoglobulin material; bioaffecting or body-treating methods of using compositions of monoclonal antibodies or fragments thereof, which monoclonal antibodies or fragments thereof are conjugated to or complexed with nonimmunoglobulin material; and said compositions, per se.

SEE OR SEARCH CLASS

435, Chemistry: Molecular Biology and Microbiology,

326+, for an animal cell, per se, which expresses immunoglobulin, antibody, or fragment thereof.

530, Chemistry: Natural Resins or Derivatives; Peptides or Proteins; Lignins or Reaction Products Thereof,

387.2+, especially subclasses 388.1+, for monoclonal antibodies, per se.